Close
Back to DTIL Stock Lookup
Pages: 1 2 3 »» Last Page

(DTIL) – Globe Newswire

Jan 9, 2024 07:00 AM TG Therapeutics Announces Global License Agreement with Precision BioSciences for the Development and Commercialization of Precision’s Allogeneic CD19 CAR T Cell Therapy Program for the Treatment of
Sep 2, 2021 02:00 AM Precision BioSciences and Tiziana Life Sciences Announce Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Cand
Sep 2, 2021 02:00 AM Precision BioSciences and Tiziana Life Sciences Announce Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Cand
Apr 6, 2021 08:35 AM Precision BioSciences Announces CEO Transition Plan
Apr 6, 2021 08:35 AM Precision BioSciences Announces CEO Transition Plan
Mar 29, 2021 07:00 AM Precision BioSciences to Participate in the Guggenheim Healthcare Talks 2021 Genomic Medicines & Rare Disease Day
Mar 29, 2021 07:00 AM Precision BioSciences to Participate in the Guggenheim Healthcare Talks 2021 Genomic Medicines & Rare Disease Day
Mar 18, 2021 07:00 AM Precision BioSciences Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Update
Mar 18, 2021 07:00 AM Precision BioSciences Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Update
Mar 12, 2021 07:00 AM Precision BioSciences to Report Fourth Quarter and Fiscal Year 2020 Financial Results on March 18, 2021
Mar 12, 2021 07:00 AM Precision BioSciences to Report Fourth Quarter and Fiscal Year 2020 Financial Results on March 18, 2021
Mar 2, 2021 07:00 AM Precision BioSciences to Present at Upcoming Virtual Investor Conferences
Mar 2, 2021 07:00 AM Precision BioSciences to Present at Upcoming Virtual Investor Conferences
Feb 19, 2021 07:00 AM Precision Announces 3-Year Pre-clinical Study Results Showing Long-term Durability and Safety of ARCUS In Vivo Gene Editing to Cut LDL Cholesterol Levels in Nonhuman Primates
Feb 19, 2021 07:00 AM Precision Announces 3-Year Pre-clinical Study Results Showing Long-term Durability and Safety of ARCUS In Vivo Gene Editing to Cut LDL Cholesterol Levels in Nonhuman Primates
Feb 4, 2021 07:00 AM Precision BioSciences to Present at Guggenheim Healthcare Talks 2021 Oncology Day
Feb 4, 2021 07:00 AM Precision BioSciences to Present at Guggenheim Healthcare Talks 2021 Oncology Day
Jan 25, 2021 07:00 AM Precision BioSciences Receives Notice of Allowance for U.S. Patent Application Covering PBCAR19B, a Stealth Cell, CD19 Allogeneic CAR T Candidate for Non-Hodgkin Lymphoma
Jan 25, 2021 07:00 AM Precision BioSciences Receives Notice of Allowance for U.S. Patent Application Covering PBCAR19B, a Stealth Cell, CD19 Allogeneic CAR T Candidate for Non-Hodgkin Lymphoma
Jan 19, 2021 07:00 AM Precision BioSciences Announces FDA Accepts IND for PBCAR19B, a Next-Generation, Stealth Cell, CD19 Allogeneic CAR T Candidate for Non-Hodgkin Lymphoma
Jan 19, 2021 07:00 AM Precision BioSciences Announces FDA Accepts IND for PBCAR19B, a Next-Generation, Stealth Cell, CD19 Allogeneic CAR T Candidate for Non-Hodgkin Lymphoma
Jan 7, 2021 07:00 AM Precision BioSciences Announces Closing of In Vivo Gene Editing Collaboration and License Agreement with Eli Lilly and Company
Jan 7, 2021 07:00 AM Precision BioSciences Announces Closing of In Vivo Gene Editing Collaboration and License Agreement with Eli Lilly and Company
Jan 4, 2021 07:00 AM Precision BioSciences to Present at the Annual J.P. Morgan Healthcare Conference
Jan 4, 2021 07:00 AM Precision BioSciences to Present at the Annual J.P. Morgan Healthcare Conference
Dec 14, 2020 12:00 AM Precision BioSciences Announces Executive Leadership Change
Dec 14, 2020 12:00 AM Precision BioSciences Announces Executive Leadership Change
Dec 11, 2020 11:00 AM Elo Life Systems Publishes the Most Detailed Genome Map in the Industry to Improve Quality and Supply Chain Stability of Vanilla
Dec 11, 2020 11:00 AM Elo Life Systems Publishes the Most Detailed Genome Map in the Industry to Improve Quality and Supply Chain Stability of Vanilla
Dec 4, 2020 06:30 AM Precision BioSciences Reports Positive Interim Results from PBCAR0191 Phase 1/2a Trial in Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) and R/R B-cell Acute Lymphoblastic Leukemia (B-ALL)
Dec 4, 2020 06:30 AM Precision BioSciences Reports Positive Interim Results from PBCAR0191 Phase 1/2a Trial in Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) and R/R B-cell Acute Lymphoblastic Leukemia (B-ALL)
Nov 24, 2020 04:05 PM Precision BioSciences to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
Nov 24, 2020 04:05 PM Precision BioSciences to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
Nov 10, 2020 07:00 AM Precision BioSciences Reports Third Quarter 2020 Financial Results and Provides Business Update
Nov 10, 2020 07:00 AM Precision BioSciences Reports Third Quarter 2020 Financial Results and Provides Business Update
Nov 3, 2020 07:00 AM Precision BioSciences to Report Third Quarter 2020 Financial Results on November 10, 2020
Nov 3, 2020 07:00 AM Precision BioSciences to Report Third Quarter 2020 Financial Results on November 10, 2020
Oct 15, 2020 07:00 AM Precision BioSciences Announces U.S. Patent Trial and Appeal Board Upholds Allogeneic CAR T Patents
Oct 15, 2020 07:00 AM Precision BioSciences Announces U.S. Patent Trial and Appeal Board Upholds Allogeneic CAR T Patents
Oct 14, 2020 07:00 AM Precision BioSciences Appoints Alex Kelly as Chief Corporate Affairs Officer
Oct 14, 2020 07:00 AM Precision BioSciences Appoints Alex Kelly as Chief Corporate Affairs Officer
Sep 28, 2020 07:00 AM Precision BioSciences to Present at Upcoming Virtual Investor Conferences in October
Sep 28, 2020 07:00 AM Precision BioSciences to Present at Upcoming Virtual Investor Conferences in October
Sep 21, 2020 07:30 AM Elo Life Systems Appoints Food and Beverage Industry Technology Leader Alec Hayes as Vice President of Technology and Products
Sep 21, 2020 07:00 AM Precision BioSciences and SpringWorks Therapeutics Announce Clinical Collaboration to Evaluate PBCAR269A in Combination with Nirogacestat in Patients with Relapsed or Refractory Multiple Myeloma
Sep 21, 2020 07:00 AM Precision BioSciences and SpringWorks Therapeutics Announce Clinical Collaboration to Evaluate PBCAR269A in Combination with Nirogacestat in Patients with Relapsed or Refractory Multiple Myeloma
Sep 17, 2020 07:00 AM Precision BioSciences and Servier Expand CAR T Oncology Development Collaboration with Four New Programs Targeting Hematological and Solid Tumors
Sep 17, 2020 07:00 AM Precision BioSciences and Servier Expand CAR T Oncology Development Collaboration with Four New Programs Targeting Hematological and Solid Tumors
Sep 9, 2020 07:00 AM Precision BioSciences Receives Fast Track Designation from U.S. Food and Drug Administration for PBCAR269A, an Investigational Allogeneic CAR T Therapy for Relapsed/Refractory Multiple Myeloma
Sep 9, 2020 07:00 AM Precision BioSciences Receives Fast Track Designation from U.S. Food and Drug Administration for PBCAR269A, an Investigational Allogeneic CAR T Therapy for Relapsed/Refractory Multiple Myeloma
Pages: 1 2 3 »» Last Page

Back to DTIL Stock Lookup